• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 4. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl bromides

Introduction to 2-bromo-5-methyl-1H-imidazole (CAS No. 23328-88-3)

2-bromo-5-methyl-1H-imidazole, identified by the Chemical Abstracts Service Number (CAS No.) 23328-88-3, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the imidazole family, a class of nitrogen-containing heterocycles that are widely recognized for their diverse biological activities and utility in medicinal chemistry. The structural features of 2-bromo-5-methyl-1H-imidazole, including the presence of a bromine substituent at the 2-position and a methyl group at the 5-position, make it a versatile intermediate in synthetic chemistry and a potential building block for the development of novel therapeutic agents.

The imidazole core is a prominent scaffold in drug discovery, owing to its ability to interact with biological targets such as enzymes and receptors. The bromine atom in 2-bromo-5-methyl-1H-imidazole serves as a reactive handle, facilitating further functionalization through cross-coupling reactions such as Suzuki-Miyaura, Stille, or Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex molecular architectures, enabling the synthesis of biaryl compounds and other pharmacophores that exhibit promising biological properties.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting various diseases, including cancer, inflammation, and infectious disorders. 2-bromo-5-methyl-1H-imidazole has emerged as a valuable precursor in this endeavor. For instance, studies have demonstrated its utility in generating imidazole-based inhibitors that modulate kinases and other signaling proteins. The brominated imidazole derivatives derived from this compound have shown inhibitory activity against several protein targets, making them attractive candidates for further development into therapeutic drugs.

One notable application of 2-bromo-5-methyl-1H-imidazole is in the synthesis of antiviral agents. The imidazole ring is a common motif in nucleoside analogs, which are known to interfere with viral replication by inhibiting key enzymes such as reverse transcriptase or polymerase. Researchers have leveraged the reactivity of 2-bromo-5-methyl-1H-imidazole to introduce diverse substituents that enhance binding affinity and selectivity against viral targets. Preliminary studies have highlighted its role in developing novel inhibitors against RNA viruses, contributing to the global effort to combat emerging infectious diseases.

The pharmaceutical industry has also explored 2-bromo-5-methyl-1H-imidazole as a starting material for creating antimicrobial compounds. Imidazole derivatives exhibit broad-spectrum activity against bacteria, fungi, and parasites due to their ability to disrupt essential cellular processes. The bromine atom at the 2-position allows for further derivatization, enabling the design of molecules with improved efficacy and reduced toxicity. Recent advances in medicinal chemistry have shown that modifications of 2-bromo-5-methyl-1H-imidazole can lead to compounds with enhanced activity against multidrug-resistant pathogens, addressing a critical unmet need in modern medicine.

From a synthetic chemistry perspective, 2-bromo-5-methyl-1H-imidazole is appreciated for its synthetic versatility. It can be readily incorporated into larger molecules through various reaction pathways, including nucleophilic substitution and metal-catalyzed coupling reactions. The methyl group at the 5-position provides additional handles for functionalization, allowing chemists to tailor the properties of derived compounds for specific applications. This flexibility has made 2-bromo-5-methyl-1H-imidazole a preferred building block in drug discovery pipelines.

The development of novel methodologies for synthesizing imidazole derivatives has further underscored the importance of 2-bromo-5-methyl-1H-imidazole. Advances in catalytic systems and green chemistry principles have enabled more efficient and sustainable routes to these compounds. For example, recent reports have described palladium-catalyzed cross-coupling reactions that proceed under mild conditions with high yields, making it feasible to produce complex imidazole-based scaffolds on scales suitable for industrial applications.

In conclusion, 2-bromo-5-methyl-1H-imidazole (CAS No. 23328-88-3) represents a crucial intermediate in modern pharmaceutical research. Its unique structural features and reactivity make it an indispensable tool for synthesizing biologically active compounds targeting various diseases. As research continues to uncover new therapeutic applications and synthetic strategies, the significance of this compound is expected to grow further, solidifying its role as a cornerstone in medicinal chemistry and drug development.

• 1067894-55-6(2-bromo-1H-Imidazole-5-carbonitrile)
• 1781173-29-2(2-bromo-5-ethyl-1H-imidazole)
• 2416229-75-7(2-bromo-4-methyl-1H-imidazole hydrobromide)
• 2460492-81-1(2-bromo-4-(methyl-d3)-1H-imidazole-5-d)
• 2302-38-7(2-bromo-4,5-dimethyl-1H-Imidazole)
• 2309446-24-8(1H-Imidazole-5-methanol, 2-bromo-, hydrochloride (1:1))
• 2445793-53-1(2-bromo-4-(propan-2-yl)-1H-imidazole hydrobromide)
• 933690-26-7(2-Bromo-1H-imidazole-5-carbaldehyde)
• 1785314-93-3(2-bromo-5-isopropyl-1H-imidazole)
• 1162674-62-5((2-Bromo-1H-imidazol-4-yl)methanol)